The Regenerative Medicine Institute (REMEDI)

The Regenerative Medicine Institute (REMEDI) is a world-class biomedical research centre focusing on gene therapy and stem cell research. We are a partnership involving scientists, clinicians, and engineers in academic centres and in industry. Researchers at REMEDI work together to combine the technologies of gene therapy and adult stem cell therapy with the aim of regeneration and repair of tissues.

Stem cell biology

This programme involves the research and use of adult human stem cells for therapeutic benefit. Research programmes at REMEDI will initially focus on the behaviour of mesenchymal stem cells and refine techniques to isolate and grow them. More importantly, researchers will investigate the factors that induce or coax stem cells to differentiate into different cell types.

Gene therapy

REMEDI researchers are focussing on the genetic modification of cells or tissues to promote tissue regeneration and/or repair for the treatment of severe diseases such as myocardial infarction, osteoarthritis and spinal cord injury.

Orthobiologics

The aim of this programme is to develop novel stem cell based therapeutics for osteoarthritis and cartilage repair. Our goal is to develop these therapies using adult bone marrow stem cells to promote the regrowth of healthy cartilage and repair damaged joints.

Immunology

This programme involves assessing host immune response to stem cell and gene therapy. Understanding how the body's immune system responds to transplanted cells and genes is critical in developing new therapeutic strategies.

Cardiovascular

The aim of this programme is to develop novel therapeutic approaches for the treatment of atherosclerotic vascular diseases. The major areas of research are in the use of mesenchymal stem cells and endothelial progenitor cells for cardiac and vascular repair, the development of medical devices for stem cell administration, the use of biomaterials for stem cell delivery in cardiovascular disease and understanding the pathogenesis of diabetic vascular disease.

Socio economic and bioethical research

This programme involves the socio-economic and bioethical aspects of stem cell and gene therapy research and explores ethical issues and socio-economic determinants and impacts in the fields of stem cell and gene therapy research.

National Stem Cell Manufacturing Facility

This is a dedicated facility to produce cellular therapeutic products such as adenoviral vectors and adult mesenchymal stem cells, according to current Good Manufacturing Practice (GMP).

Researchers at REMEDI have access to the following facilities and equipment:

Please visit our jobs section for a complete list of current vacancies.

Stem cell biology

This programme involves the research and use of adult human stem cells for therapeutic benefit. Research programmes at REMEDI will initially focus on the behaviour of mesenchymal stem cells and refine techniques to isolate and grow them. More importantly, researchers will investigate the factors that induce or coax stem cells to differentiate into different cell types.

Gene therapy

REMEDI researchers are focussing on the genetic modification of cells or tissues to promote tissue regeneration and/or repair for the treatment of severe diseases such as myocardial infarction, osteoarthritis and spinal cord injury.

Orthobiologics

The aim of this programme is to develop novel stem cell based therapeutics for osteoarthritis and cartilage repair. Our goal is to develop these therapies using adult bone marrow stem cells to promote the regrowth of healthy cartilage and repair damaged joints.

Immunology

This programme involves assessing host immune response to stem cell and gene therapy. Understanding how the body's immune system responds to transplanted cells and genes is critical in developing new therapeutic strategies.

Cardiovascular

The aim of this programme is to develop novel therapeutic approaches for the treatment of atherosclerotic vascular diseases. The major areas of research are in the use of mesenchymal stem cells and endothelial progenitor cells for cardiac and vascular repair, the development of medical devices for stem cell administration, the use of biomaterials for stem cell delivery in cardiovascular disease and understanding the pathogenesis of diabetic vascular disease.

Socio economic and bioethical research

This programme involves the socio-economic and bioethical aspects of stem cell and gene therapy research and explores ethical issues and socio-economic determinants and impacts in the fields of stem cell and gene therapy research.

National Stem Cell Manufacturing Facility

This is a dedicated facility to produce cellular therapeutic products such as adenoviral vectors and adult mesenchymal stem cells, according to current Good Manufacturing Practice (GMP).

Researchers at REMEDI have access to the following facilities and equipment: